EIF4A2
Summary:
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:601102 Ensembl IDEnsembl:ENSG00000156976 HGNC IDHGNC:HGNC:3284 PHARMGKB IDPA27712 Map Location3q27.3 |
GO terms in EIF4A2
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | HDA | GO:0003723 | RNA binding |
MF | IEA | GO:0003743 | translation initiation factor activity |
MF | TAS | GO:0004386 | helicase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IDA | GO:0016887 | ATPase activity |
Gene expression in normal tissue: EIF4A2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in EIF4A2
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1169408 | ISG15 antiviral mechanism |
reactome | R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes |
reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
reactome | R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-392499 | Metabolism of proteins |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in EIF4A2
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |